domingo, 22 de abril de 2018

Should decisions on adding adjuvant chemotherapy in early stage ER positive breast cancer be based on gene expression testing or clinicopathologic ... - PubMed - NCBI

Should decisions on adding adjuvant chemotherapy in early stage ER positive breast cancer be based on gene expression testing or clinicopathologic ... - PubMed - NCBI



 2018 Apr 4. doi: 10.1093/annonc/mdy115. [Epub ahead of print]

Should decisions on adding adjuvant chemotherapy in early stage ER positive breast cancer be based on gene expression testing or clinicopathologic factors or both?


PMID:
 
29635411
 
DOI:
 
10.1093/annonc/mdy115

No hay comentarios:

Publicar un comentario